Medicare managed care plans would face tighter restrictions and increased scrutiny of their prior authorization activity in 2026 under a proposed rule released Tuesday by the Biden administration.
In addition to proposing Medicare and Medicaid cover anti-obesity drugs for weight loss, the Contract Year 2026 Medicare Advantage and Part D proposed rule (RIN 0938-AV40) would clarify when private MA plans can apply prior authorization and other utilization management techniques by defining the meaning of “internal coverage criteria,” the Centers for Medicare & Medicaid Services announced.
The proposal would also require plans to inform enrollees of their rights to ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.